E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/31/2015 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse prices $580,000 trigger phoenix autocallables tied to CVS

By Susanna Moon

Chicago, Dec. 31 – Credit Suisse AG, London Branch priced $580,000 of trigger phoenix autocallable optimization securities due Dec. 31, 2018 linked to CVS Health Corp. shares, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annualized rate of 7% if the stock closes at or above the coupon barrier level – 78.5% of the initial price – on an observation date for that quarter.

The notes will be called at par plus the contingent coupon if the shares close at or above the initial price on any quarterly observation date after six months.

The payout at maturity will be par plus the contingent coupon unless CVS shares finish below the 78.5% trigger level, in which case investors will be fully exposed to any losses.

UBS Financial Services Inc. will be the distributor.

Issuer:Credit Suisse AG, London Branch
Issue:Trigger phoenix autocallable optimization securities
Underlying stock:CVS Health Corp. (Symbol: CVS)
Amount:$580,000
Maturity:Dec. 31, 2018
Coupon:7%, payable quarterly if stock closes at or above coupon barrier level on observation date for that quarter
Price:Par of $10.00
Payout at maturity:Par plus contingent coupon if CVS shares finish at or above trigger price; otherwise, par plus stock return
Call:At par plus contingent coupon if CVS shares close at or above initial price on a quarterly observation date after six months
Initial share price:$99.36
Barrier level:$78.00, 78.5% of initial price
Pricing date:Dec. 29
Settlement date:Dec. 31
Distributor:UBS Financial Services Inc.
Fees:2%
Cusip:22548J358

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.